Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy.
Fledrich R, Abdelaal T, Rasch L, Bansal V, Schütza V, Brügger B, Lüchtenborg C, Prukop T, Stenzel J, Rahman RU, Hermes D, Ewers D, Möbius W, Ruhwedel T, Katona I, Weis J, Klein D, Martini R, Brück W, Müller WC, Bonn S, Bechmann I, Nave KA, Stassart RM, Sereda MW.
Fledrich R, et al. Among authors: hermes d.
Nat Commun. 2018 Aug 2;9(1):3025. doi: 10.1038/s41467-018-05420-0.
Nat Commun. 2018.
PMID: 30072689
Free PMC article.